gms | German Medical Science

21st Annual Meeting of the German Retina Society and 8th Symposium of the International Society of Ocular Trauma (ISOT)

German Retina Society
International Society of Ocular Trauma

19.06. - 22.06.2008, Würzburg

RG4: Anti-VEGF bei AMD

Meeting Abstract (ISOTRG2008V110)

1-year-results of Bevacizumab therapy for subfoveal choroidal neovascularisations in age related macular degeneration

Schrader WF, Walter L
[Full Text]
Meeting Abstract (ISOTRG2008V111)

Efficicy and Safety of Intravitreal Bevacizumab (Avastin) on demand in neovascular Age-related Macular Degeneration. 12 Months Results.

Müller B, Porstmann AU
[Full Text]
Meeting Abstract (ISOTRG2008V112)

Up-date on the Avastin database

Meyer CH
[Full Text]
Meeting Abstract (ISOTRG2008V113)

The use of anti-VEGF Inhibitors in wet AMD: balancing the risks

Blank R
With Erratum (Jun 25, 2008)
[Full Text]
Meeting Abstract (ISOTRG2008V114)

Inclusion and withdrawal criteria of intravitreal injections with ranibizumab (Lucentis®) in neovascular ARMD

Dave H, Wiegand W
[Full Text]
Meeting Abstract (ISOTRG2008V115)

Ranibizumab for neovascular ARMD: Results of the Excite- and Sustatin-Studies

Eter NN, Meyer C, Clemens C, Holz FG
[Full Text]
Meeting Abstract (ISOTRG2008V116)

Frühzeitige Behandlung mit Ranibizumab (Lucentis®) bei exsudativer AMD als notwendige Voraussetzung für Erfolg

Matthé E, Sandner D, Pillunat LE
[Full Text]
Meeting Abstract (ISOTRG2008V117)

Combined Intravitreal Bevacizumab and Triamcinolone for Exudative Age-Related Macular Degeneration

Schlichtenbrede FC, Jonas JB, Libondi T, Golubkina L, Spandau UH, Rensch F
[Full Text]
Meeting Abstract (ISOTRG2008V118)

Low-dose triamcinolone prolongs the effect of bevacizumab in patients with acute exsudative age related macular degeneration

Gerding H, Riese J, Loukopoulos V, Meier C, Timmermann M
[Full Text]
Meeting Abstract (ISOTRG2008V119)

Ist die PDT noch aktuell?

Kaymak H, Mohammad G, Mester U
[Full Text]
Meeting Abstract (ISOTRG2008V120)

Photodynamic Therapy with Verteporfin combined with Intravitreal Injection of Ranibizumab for Occult and Classic CNV in AMD

Maier M, Feucht N, Fiore B, Winkler C, von Mohrenfels C, Kook P, Fegert C, Lohmann CP
[Full Text]
Meeting Abstract (ISOTRG2008V121)

Combination therapy for exudative ARMD: IECOMB study

Wolf S, Brinkmann CK, Berger L, Wolf-Schnurrbusch UEK
[Full Text]
Meeting Abstract (ISOTRG2008V122)

Fundusautofluoreszenz nach intravitrealer VEGF-Hemmer Gabe

Hager A, Wiegand W
[Full Text]
Meeting Abstract (ISOTRG2008V123)

Prognostische Faktoren bei der Anti-VEGF-Therapie der exsudativen AMD

Pauleikhoff D, Heimes B, Dietzel M, Zeimer M, Spital G, Lommatzsch A
[Full Text]
Meeting Abstract (ISOTRG2008V124)

Gene therapy for retinal degeneration

Thumann G, Stöcker M, Walter P, Johnen S
[Full Text]